|
US5206018A
(en)
|
1978-11-03 |
1993-04-27 |
Ayerst, Mckenna & Harrison, Inc. |
Use of rapamycin in treatment of tumors
|
|
IT1197485B
(it)
*
|
1986-10-07 |
1988-11-30 |
Boehringer Biochemia Srl |
Composizioni farmaceutiche ad attivita' antineoplastica
|
|
US5540931A
(en)
|
1989-03-03 |
1996-07-30 |
Charles W. Hewitt |
Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
|
|
US5650156A
(en)
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
DK0693924T4
(da)
|
1993-02-22 |
2008-08-04 |
Abraxis Bioscience Inc |
Fremgangsmåde til (in vivo) levering af biologiske materialer og sammensætninger, der er egnede dertil
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US20070116761A1
(en)
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030068362A1
(en)
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
|
US5997904A
(en)
|
1993-02-22 |
1999-12-07 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US6528067B1
(en)
|
1993-02-22 |
2003-03-04 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US5665383A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of immunostimulating agents for in vivo delivery
|
|
US5362478A
(en)
|
1993-03-26 |
1994-11-08 |
Vivorx Pharmaceuticals, Inc. |
Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
|
|
US5665382A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
EP1683517A1
(en)
|
1996-08-19 |
2006-07-26 |
American Bioscience, Inc. |
Methods for the production of protein particles useful for delivery of pharmacological agents
|
|
US20070092563A1
(en)
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
IL132094A0
(en)
*
|
1997-03-27 |
2001-03-19 |
Baker Norton Pharma |
Methods and compositions for treatment of ovarian cancer
|
|
NZ502500A
(en)
|
1997-06-27 |
2002-03-28 |
Vivorx Pharmaceuticals Inc |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030199425A1
(en)
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
US8853260B2
(en)
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
AU777528B2
(en)
|
1999-04-22 |
2004-10-21 |
Abraxis Bioscience, Llc |
Long term administration of pharmacologically active agents
|
|
CA2684454A1
(en)
|
1999-05-21 |
2000-11-18 |
American Bioscience, Llc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
ITMI20001107A1
(it)
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
|
|
EP1385551B1
(en)
|
2001-04-06 |
2008-09-03 |
Wyeth |
Antineoplastic combinations comprising cci-779 (rapamycin derivative) together with gemcitabine or fluorouracil
|
|
US20030054042A1
(en)
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
WO2003086178A2
(en)
|
2002-04-11 |
2003-10-23 |
Children's Medical Center Corporation |
Methods for inhibiting vascular hyperpermeability
|
|
US20040126400A1
(en)
|
2002-05-03 |
2004-07-01 |
Iversen Patrick L. |
Delivery of therapeutic compounds via microparticles or microbubbles
|
|
KR20150108943A
(ko)
|
2002-12-09 |
2015-09-30 |
아브락시스 바이오사이언스, 엘엘씨 |
약리학적 물질의 조성물 및 그 전달방법
|
|
EP1585548B1
(en)
|
2002-12-09 |
2018-06-27 |
Abraxis BioScience, LLC |
Compositions and methods of delivery of pharmacological agents
|
|
AU2003293529A1
(en)
|
2002-12-16 |
2004-07-29 |
Nitromed, Inc. |
Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
|
|
US20050119330A1
(en)
|
2003-03-17 |
2005-06-02 |
Kao Peter N. |
Use of antiproliferative agents in the treatment and prevention of pulmonary proliferative vascular diseases
|
|
US20050038498A1
(en)
|
2003-04-17 |
2005-02-17 |
Nanosys, Inc. |
Medical device applications of nanostructured surfaces
|
|
US20050152979A1
(en)
|
2003-09-05 |
2005-07-14 |
Cell Therapeutics, Inc. |
Hydrophobic drug compositions containing reconstitution enhancer
|
|
DE10347994A1
(de)
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
|
MXPA06013191A
(es)
|
2004-05-14 |
2007-07-24 |
Abraxis Bioscience Inc |
Metodos de tratamiento que utilizan proteinas que enlazan albumina como objetivos.
|
|
EP1793803B1
(en)
|
2004-10-01 |
2012-11-07 |
Ramscor, Inc. |
Conveniently implantable sustained release drug compositions
|
|
WO2006053754A1
(en)
|
2004-11-19 |
2006-05-26 |
Novartis Ag |
COMBINATIONS OF ANTI-ATHEROSCLEROTIC PEPTIDES AND AN mTOR INHIBITING AGENT AND THEIR METHODS OF USE
|
|
EP1861070B1
(en)
|
2005-02-18 |
2018-01-17 |
Abraxis BioScience, LLC |
Drugs with improved hydrophobicity for incorporation in medical devices
|
|
SI3248600T1
(sl)
|
2005-02-18 |
2020-09-30 |
Abraxis Bioscience, Llc |
Kombinacije in načini dajanja terapevtskih sredstev in kombinacijska terapija
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
US20070166388A1
(en)
|
2005-02-18 |
2007-07-19 |
Desai Neil P |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
CN101175481A
(zh)
|
2005-03-17 |
2008-05-07 |
伊兰制药国际有限公司 |
纳米颗粒免疫抑制化合物的可注射的组合物
|
|
WO2006113579A2
(en)
|
2005-04-16 |
2006-10-26 |
Michigan State University |
Tumor inhibition by modulating sprouty expression or activity
|
|
AU2006247473A1
(en)
|
2005-05-16 |
2006-11-23 |
Novartis Ag |
The use of rapamycin derivatives for the treatment and/or prevention of cardiovascular disorders
|
|
PL1931321T3
(pl)
|
2005-08-31 |
2019-08-30 |
Abraxis Bioscience, Llc |
Kompozycje zawierające słabo rozpuszczalne w wodzie środki farmaceutyczne i środki przeciwdrobnoustrojowe
|
|
EP3527202A1
(en)
|
2005-08-31 |
2019-08-21 |
Abraxis BioScience, LLC |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
|
US20080280987A1
(en)
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
EP2056812A1
(en)
|
2006-08-31 |
2009-05-13 |
Abraxis BioScience, LLC |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
US20100112077A1
(en)
|
2006-11-06 |
2010-05-06 |
Abraxis Bioscience, Llc |
Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
|
|
ITFI20060277A1
(it)
*
|
2006-11-08 |
2008-05-09 |
Giuliano Giustini |
Sollevatore per motociclette e simili, offrente mobilita' di spostamenti omnidirezionali
|
|
EP3470071A1
(en)
|
2006-12-14 |
2019-04-17 |
Abraxis BioScience, LLC |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
|
LT2481402T
(lt)
|
2007-03-07 |
2018-10-25 |
Abraxis Bioscience, Llc |
Nanodalelė, apimanti rapamiciną ir albuminą, kaip priešvėžinį agentą
|
|
CA2686736A1
(en)
|
2007-05-03 |
2008-11-13 |
Abraxis Bioscience, Llc |
Nanoparticle compositions comprising rapamycin for treating pulmonary hypertension
|
|
WO2008150532A1
(en)
|
2007-06-01 |
2008-12-11 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
|
CA2721153C
(en)
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
MX2011006167A
(es)
|
2008-12-11 |
2011-07-28 |
Abraxis Bioscience Llc |
Combinaciones y modos de administracion de agentes terapeuticos y terapia de combinacion.
|
|
JP5725563B2
(ja)
|
2009-03-13 |
2015-05-27 |
アブラクシス バイオサイエンス， エルエルシー |
チオコルヒチン誘導体との組み合わせ療法
|
|
CA2758200A1
(en)
|
2009-04-10 |
2010-10-14 |
Abraxis Bioscience, Llc |
Nanoparticle formulations and uses thereof
|
|
MX378130B
(es)
|
2009-04-15 |
2025-03-10 |
Abraxis Bioscience Llc |
Métodos y composiciones de nanopartículas sin priones.
|
|
MX340670B
(es)
|
2009-08-25 |
2016-07-20 |
Abraxis Bioscience Llc * |
Terapia combinada con composiciones de nanoparticulas de taxano e inhibidores de hedgehog.
|
|
US9775819B2
(en)
|
2009-09-16 |
2017-10-03 |
R.P. Scherer Technologies, Llc |
Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
|
|
US8269348B2
(en)
*
|
2010-02-22 |
2012-09-18 |
Texas Instruments Incorporated |
IC die including RDL capture pads with notch having bonding connectors or its UBM pad over the notch
|
|
PT2552438T
(pt)
|
2010-03-26 |
2016-07-07 |
Abraxis Bioscience Llc |
Métodos de tratamento de carcinoma hepatocelular
|
|
AU2011232862B2
(en)
|
2010-03-29 |
2016-03-03 |
Abraxis Bioscience, Llc |
Methods of enhancing drug delivery and effectiveness of therapeutic agents
|
|
EP3141245A1
(en)
|
2010-03-29 |
2017-03-15 |
Abraxis BioScience, LLC |
Methods of treating cancer
|
|
ES2639038T3
(es)
|
2010-06-02 |
2017-10-25 |
Abraxis Bioscience, Llc |
Métodos para el tratamiento de cáncer de vejiga
|
|
BR112012030909A2
(pt)
|
2010-06-04 |
2020-08-18 |
Abraxis Bioscience, Llc |
métodos de tratamento de câncer pancreático
|
|
AU2011264590B2
(en)
|
2010-06-07 |
2016-12-15 |
Abraxis Bioscience, Llc |
Combination therapy methods for treating proliferative diseases
|
|
US8871256B2
(en)
*
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and systems for treatment of inflammatory diseases with nitric oxide
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
US20140186447A1
(en)
|
2012-12-28 |
2014-07-03 |
Abraxis Bioscience, Llc |
Nanoparticle compositions of albumin and paclitaxel
|
|
US20140199405A1
(en)
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on mutation status of k-ras
|
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
US20140199404A1
(en)
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on level of a nucleoside transporter
|